TY - JOUR
T1 - Share and share alike
T2 - Deciding how to distribute the scientific and social benefits of genomic data
AU - Foster, Morris W.
AU - Sharp, Richard R.
N1 - Funding Information:
This paper was supported in part by the US National Cancer Institute (NCI), the US National Center for Research Resources (NCRR), the US National Institute on Environmental Health Sciences (NIEHS) and the US National Human Genome Research Institute (NHGRI). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NCI, NCRR, NIEHS, NHGRI or the US National Institutes of Health.
PY - 2007/8/3
Y1 - 2007/8/3
N2 - Emerging technologies make genomic analyses more efficient and less expensive, enabling genome-wide association and gene-environment interaction studies. In anticipation of their results, funding agencies such as the US National Institutes of Health and the Wellcome Trust are formulating guidelines for sharing the large amounts of genomic data that are generated by the projects that they sponsor. Data-sharing policies can have varying implications for how disease susceptibility and drug-response research will be pursued by the scientific community, and for who will benefit from the resulting medical discoveries. We suggest that the complex interplay of stakeholders and their interests, rather than single-issue and single-stakeholder perspectives, should be considered when deciding genomic data-sharing policies.
AB - Emerging technologies make genomic analyses more efficient and less expensive, enabling genome-wide association and gene-environment interaction studies. In anticipation of their results, funding agencies such as the US National Institutes of Health and the Wellcome Trust are formulating guidelines for sharing the large amounts of genomic data that are generated by the projects that they sponsor. Data-sharing policies can have varying implications for how disease susceptibility and drug-response research will be pursued by the scientific community, and for who will benefit from the resulting medical discoveries. We suggest that the complex interplay of stakeholders and their interests, rather than single-issue and single-stakeholder perspectives, should be considered when deciding genomic data-sharing policies.
UR - http://www.scopus.com/inward/record.url?scp=34447561714&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34447561714&partnerID=8YFLogxK
U2 - 10.1038/nrg2124
DO - 10.1038/nrg2124
M3 - Review article
C2 - 17607307
AN - SCOPUS:34447561714
SN - 1471-0056
VL - 8
SP - 633
EP - 639
JO - Nature Reviews Genetics
JF - Nature Reviews Genetics
IS - 8
ER -